Neuroprotective effects of 2DG in traumatic brain injury
This invention provides methods for reducing the extent and progression of traumatic brain injury and its deleterious sequellae specifically cognitive decline, post-traumatic epilepsy, post-traumatic stress disorder, and other adverse consequences depending on the progression of the initial injury, comprising administering to a TBI victim in need thereof a therapeutically-effective amount of an antiglycolytic compound, particularly 2-deoxyglucose (2-DG) or glycolysis-inhibiting analogs thereof. The invention also provides pharmaceutical compositions of 2-DG or glycolysis-inhibiting analogs thereof for use in the methods of the invention.
1. A method for reducing severity, progression and associated symptoms of a traumatic brain injury comprising administering to an animal in need thereof a therapeutic amount of an antiglycolytic compound, wherein the severity, progression and associated symptoms of the traumatic brain injury is selected from the group consisting of concussion, progressive brain atrophy, brain cell loss, brain tissue structure reorientation due to injury, and white matter damage.
2. The method of claim 1 , wherein the antiglycolytic compound is 2-deoxyglucose (2-DG), 3-deoxy-D-glucose, 4-deoxy-D-glucose, 5-deoxy-D-glucose, 2, n-deoxy-D-glucose, where n=3-5, n, m deoxy-D-glucose, where n=2-5 and m=integers from 2-5 excluding n, sugars that can be metabolized into 2-DG, halogenated and other conjugated derivatives of deoxy sugars, conjugated deoxy sugars that are metabolized to 2-DG, and antiglycolytic compounds having antiglycolytic effects similar to 2-DG.
3. The method of claim 2 , wherein the antiglycolytic compound is 2-DG.
4. The method of claim 1 , wherein the animal is a human.
5. The method of claim 1 , wherein the antiglycolytic compound is administered to the animal for two weeks.
6. The method of claim 1 , wherein the antiglycolytic compound is administered to the animal for over two weeks.
7. A method for reducing severity and progression of concussion resulting from a traumatic brain injury comprising administering to an animal in need thereof a therapeutic amount of 2-deoxyglucose.